Ikarian-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
141
Total Value
710178588
Accession Number
0001420506-25-001276
Form Type
13F-HR
Manager Name
Ikarian-Capital
Data Enrichment
96% identified
135 identified6 unidentified

Holdings

141 positions
Manager:
Search and click to pin securities to the top
Page 2 of 8
Viridian Therapeutics, Inc.\DE
Shares:494.9K
Value:$6.7M
INSMED Inc
Shares:84.8K
Value:$6.5M
Edgewise Therapeutics, Inc.
Shares:280.0K
Value:$6.2M
CATALYST PHARMACEUTICALS, INC.
Shares:249.6K
Value:$6.1M
CYTOKINETICS INC
Shares:150.0K
Value:$6.0M
Enliven Therapeutics, Inc.
Shares:289.5K
Value:$5.7M
Praxis Precision Medicines, Inc.
Shares:145.5K
Value:$5.5M
Cidara Therapeutics, Inc.
Shares:248.9K
Value:$5.4M
Alpha Cognition Inc.
Shares:967.9K
Value:$5.1M
Protagonist Therapeutics, Inc
Shares:100.0K
Value:$4.8M
Tectonic Therapeutic, Inc.
Shares:269.1K
Value:$4.8M
Forte Biosciences, Inc.
Shares:609.2K
Value:$4.7M
Structure Therapeutics Inc.
Shares:264.1K
Value:$4.6M
Ultragenyx Pharmaceutical Inc.
Shares:113.1K
Value:$4.1M
59267L107
Shares:150.0K
Value:$4.1M
Neuronetics, Inc.
Shares:1.1M
Value:$4.0M
CAPRICOR THERAPEUTICS, INC.
Shares:400.0K
Value:$3.8M
MoonLake Immunotherapeutics
Shares:94.5K
Value:$3.7M
INCYTE CORP
Shares:60.4K
Value:$3.7M
Viking Therapeutics, Inc.
Shares:150.0K
Value:$3.6M